• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幼年内脏脂肪变性小鼠中钠依赖性肉碱转运体小鼠OCTN2的错义突变。

A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse.

作者信息

Lu K m, Nishimori H, Nakamura Y, Shima K, Kuwajima M

机构信息

Department of Laboratory Medicine, School of Medicine, Tokushima University, Tokushima, 770-8503, Japan.

出版信息

Biochem Biophys Res Commun. 1998 Nov 27;252(3):590-4. doi: 10.1006/bbrc.1998.9708.

DOI:10.1006/bbrc.1998.9708
PMID:9837751
Abstract

Carnitine is an essential cofactor for the mitochondrial beta-oxidation of long-chain fatty acids. The juvenile visceral steatosis (JVS) mouse, an animal model of systemic carnitine deficiency, is inherited in an autosomal recessive manner. Recently, a human OCTN2 gene encoding a sodium-dependent carnitine cotransporter was isolated and mapped to human chromosome 5q31. Since the mouse jvs locus was assigned to the region of chromosome 11 where it is syntenic to human chromosome 5q31, we isolated the mouse octn2 gene and screened for its mutation in the jvs mouse. DNA sequencing analysis disclosed a missense mutation from CTG (Leu) to CGG (Arg) at codon 352 located within the sixth transmembrane domain of octn2. This amino acid replacement possibly causes the conformational change of the protein that leads to dysfunction of the gene product. Hence, we conclude that octn2 is a candidate gene responsible for the JVS mouse.

摘要

肉碱是长链脂肪酸线粒体β氧化的必需辅助因子。幼年内脏脂肪变性(JVS)小鼠是全身性肉碱缺乏的动物模型,以常染色体隐性方式遗传。最近,一个编码钠依赖性肉碱协同转运蛋白的人类OCTN2基因被分离出来并定位到人类染色体5q31。由于小鼠jvs基因座被定位到11号染色体上与人染色体5q31同线的区域,我们分离了小鼠octn2基因并在JVS小鼠中筛选其突变。DNA序列分析揭示在octn2第六跨膜结构域内的第352密码子处有一个从CTG(亮氨酸)到CGG(精氨酸)的错义突变。这种氨基酸替换可能导致蛋白质的构象变化,从而导致基因产物功能障碍。因此,我们得出结论,octn2是导致JVS小鼠发病的候选基因。

相似文献

1
A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse.幼年内脏脂肪变性小鼠中钠依赖性肉碱转运体小鼠OCTN2的错义突变。
Biochem Biophys Res Commun. 1998 Nov 27;252(3):590-4. doi: 10.1006/bbrc.1998.9708.
2
Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.原发性肉碱缺乏症中有机阳离子/肉碱转运体OCTN2的突变。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2356-60. doi: 10.1073/pnas.96.5.2356.
3
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.原发性系统性肉碱缺乏症是由编码钠离子依赖性肉碱转运体的基因突变引起的。
Nat Genet. 1999 Jan;21(1):91-4. doi: 10.1038/5030.
4
Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.肉碱/有机阳离子转运体OCTN2多功能性的分子和生理学证据。
Mol Pharmacol. 2001 Feb;59(2):358-66. doi: 10.1124/mol.59.2.358.
5
Carnitine transport: pathophysiology and metabolism of known molecular defects.肉碱转运:已知分子缺陷的病理生理学与代谢
J Inherit Metab Dis. 2003;26(2-3):147-69. doi: 10.1023/a:1024481016187.
6
Carnitine transport by organic cation transporters and systemic carnitine deficiency.有机阳离子转运体介导的肉碱转运与全身性肉碱缺乏症
Mol Genet Metab. 2001 Aug;73(4):287-97. doi: 10.1006/mgme.2001.3207.
7
A heterozygote phenotype is present in the jvs +/- mutant mouse livers.在jvs +/-突变小鼠肝脏中存在杂合子表型。
Mol Genet Metab. 2002 May;76(1):76-80. doi: 10.1016/s1096-7192(02)00017-3.
8
Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency.OCTN2(一种有机阳离子/肉碱转运体)的突变会导致原发性肉碱缺乏症中细胞对肉碱的摄取不足。
Hum Mol Genet. 1999 Apr;8(4):655-60. doi: 10.1093/hmg/8.4.655.
9
Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.肉碱缺乏的jvs(OCTN2(-/-))小鼠肠道和结肠萎缩及炎症的自发发展
Mol Genet Metab. 2007 Dec;92(4):315-24. doi: 10.1016/j.ymgme.2007.08.002. Epub 2007 Sep 19.
10
Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency.三名系统性肉碱缺乏症患者OCTN2基因中两个新突变的鉴定。
Hum Genet. 1999 Jul-Aug;105(1-2):157-61. doi: 10.1007/s004399900105.

引用本文的文献

1
Organic Cation Transporter Expression and Function in the CNS.中枢神经系统中有机阳离子转运体的表达与功能
Handb Exp Pharmacol. 2021;266:41-80. doi: 10.1007/164_2021_463.
2
Reduced 24-h Sodium Excretion Is Associated With a Disturbed Plasma Acylcarnitine Profile in Vasovagal Syncope Children: A Pilot Study.24小时钠排泄减少与血管迷走性晕厥儿童血浆酰基肉碱谱紊乱有关:一项初步研究。
Front Pediatr. 2020 Mar 11;8:98. doi: 10.3389/fped.2020.00098. eCollection 2020.
3
Molecular Mechanisms of Colistin-Induced Nephrotoxicity.多黏菌素诱导肾毒性的分子机制。
Molecules. 2019 Feb 12;24(3):653. doi: 10.3390/molecules24030653.
4
Uptake carriers and oncology drug safety.摄取载体和肿瘤药物安全。
Drug Metab Dispos. 2014 Apr;42(4):611-22. doi: 10.1124/dmd.113.055806. Epub 2013 Dec 30.
5
Cisplatin-induced downregulation of OCTN2 affects carnitine wasting.顺铂诱导的 OCTN2 下调影响肉碱流失。
Clin Cancer Res. 2010 Oct 1;16(19):4789-99. doi: 10.1158/1078-0432.CCR-10-1239. Epub 2010 Sep 21.
6
Xenobiotic, bile acid, and cholesterol transporters: function and regulation.异生素、胆汁酸和胆固醇转运蛋白:功能与调节。
Pharmacol Rev. 2010 Mar;62(1):1-96. doi: 10.1124/pr.109.002014. Epub 2010 Jan 26.
7
Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.多特异性有机阳离子转运体:结构、功能、生理作用及生物制药意义
Pharm Res. 2007 Jul;24(7):1227-51. doi: 10.1007/s11095-007-9254-z. Epub 2007 May 1.
8
Carnitine transport: pathophysiology and metabolism of known molecular defects.肉碱转运:已知分子缺陷的病理生理学与代谢
J Inherit Metab Dis. 2003;26(2-3):147-69. doi: 10.1023/a:1024481016187.
9
Identification of human CDV-1R and mouse Cdv-1R, two novel proteins with putative signal peptides, especially highly expressed in testis and increased with the male sex maturation.人CDV-1R和小鼠Cdv-1R的鉴定,这两种具有假定信号肽的新型蛋白质,尤其在睾丸中高表达,并随着雄性性成熟而增加。
Mol Biol Rep. 2002 Dec;29(4):353-62. doi: 10.1023/a:1021232518628.
10
Carnitine biosynthesis in mammals.哺乳动物中的肉碱生物合成。
Biochem J. 2002 Feb 1;361(Pt 3):417-29. doi: 10.1042/0264-6021:3610417.